Simple Summary Breast and prostate cancers are serious public health issues that create
considerable burden to both people and healthcare systems worldwide. Cancer is a …

Through the revolutionization of artificial intelligence (AI) technologies in clinical research,
significant improvement is observed in diagnosis of cancer. Utilization of these AI …

Prostate cancer (PCa) is the most common malignant tumor and the second leading cause
of cancer-related mortality in men worldwide. Despite significant advances in PCa therapy …

Introduction Gene identification for genetic diseases is critical for the development of new
diagnostic approaches and personalized treatment options. Prioritization of gene translation …

Background Cancer is progressively becoming the most prevalent disease worldwide,
accompanied by significantly increasing investments in research to improve its prevention …

Artificial intelligence (AI) as a technology concept is making a major impact on a wide range
of industries and sectors. This is largely attributed to technical advancements in machine …

Background: Prostate cancer (PCa) is occurred with increasing incidence and
heterogeneous pathogenesis. Although clinical strategies are accumulated for PCa …

Point-of-care detection of tumor biomarkers with high sensitivity remains an enormous
challenge in the early diagnosis and mass screening of cancer. Fluorescent lateral flow …

Long non-coding RNAs (lncRNAs) are non-coding RNAs that have more than 200
nucleotides and can participate in the regulation of gene expression in various ways. An …

Personalized medicine requires large cohorts for patient stratification and validation of
patient clustering. However, standards and harmonized practices on the methods and tools …